Case histories

When it mattered, we were in the room.

Real programmes and real outcomes, from first-in-human studies to approval. See how biotech, pharma and academic partners have worked with Niche.

20case histories Request a proposal →

Trusted by biotech, pharma and research teams

ReCode Therapeutics Inc. Erytech Pharma SA DemeRx Cleothena Enterprises Pty Ltd British Society for Haematology Cardionetics Recardio Inc Surface Logix Inc ViiV Healthcare Synairgen plc Orchard Therapeutics plc Nabriva Therapeutics EVERSANA Adaptimmune FRAILomic RASP-UK initiative MID-Frail Study Astex Pharmaceuticals ApaTech Assign DMB

All case histories

Work that speaks for itself.

Service
Area

20 of 20 case histories

Respiratory Clinical OperationsRegulatory Affairs ReCode Therapeutics Inc. Niche supported ReCode Therapeutics in launching their first UK patient study, delivering end-to-end clinical and regulatory operations for pioneering mRNA and gene correction therapies. Read the case history → Oncology Regulatory Affairs Erytech Pharma SA Niche partnered with Erytech Pharma to rescue and rewrite substandard clinical study reports, delivering a high-quality regulatory package in support of their oncology BLA submission. Read the case history → Neuroscience Clinical OperationsRegulatory Affairs DemeRx Niche provided DemeRx with end-to-end support to launch a pioneering ibogaine addiction trial, covering site identification, regulatory submissions, and interim medical leadership. Read the case history → Neuroscience Regulatory Affairs Cleothena Enterprises Pty Ltd When stalled regulatory documentation threatened to derail their neurological programme, Cleothena turned to Niche — who delivered standout clinical protocols and an Investigator's Brochure with minimal client input. Read the case history → Haematology Medical Communications British Society for Haematology Over a decade and 20+ guidelines later, Niche remains the BSH's trusted partner for raising haematology care standards through literature reviews, writing support and audit documentation. Read the case history → Cardiovascular Medical CommunicationsRegulatory Affairs Cardionetics A partnership born in 2002, Niche has supported Cardionetics across medical writing, regulatory strategy and product value assessment for their pioneering ECG arrhythmia detection devices. Read the case history → Cardiovascular Regulatory AffairsMedical Communications Recardio Inc From Phase 2 through to the global Phase 3 HEAL-MI trial, Niche has been Recardio's trusted writing and regulatory partner in advancing dutogliptin as a cardiac regeneration therapy. Read the case history → Multiple areas Clinical OperationsRegulatory Affairs Surface Logix Inc Trusted as Legal Representative and on-the-ground CRO, Niche became integral to Surface Logix's EU clinical team, delivering four trials across three assets in just 24 months. Read the case history → Infectious disease Medical Communications ViiV Healthcare Putting patients first, Niche supported ViiV Healthcare's global HIV outreach programmes with medical writing, communications planning and bespoke research into worldwide access to HIV medicines. Read the case history → Respiratory Medical Communications Synairgen plc At the height of the pandemic, Niche's rapid manuscript writing helped Synairgen publish their landmark interferon beta COVID-19 trial results, unlocking the company's largest ever fundraising round. Read the case history → Rare disease and gene therapy Regulatory Affairs Orchard Therapeutics plc Niche played a foundational role in securing EMA approval for Strimvelis, the world's first ex vivo autologous gene therapy, and continues supporting Orchard's pioneering rare disease pipeline. Read the case history → Infectious disease Regulatory AffairsMedical Communications Nabriva Therapeutics Niche supported Nabriva's antibiotic lefamulin from early clinical protocols all the way to FDA, EMA and Health Canada approval — a decade-long writing partnership with a genuinely world-changing outcome. Read the case history → Neuroscience Regulatory Affairs EVERSANA When an Alzheimer's programme hit a wall after two negative Phase III trials, EVERSANA called on Niche to make sense of the data and chart a credible path forward with regulators. Read the case history → Oncology Regulatory Affairs Adaptimmune Niche delivered rigorous QC and medical writing support across Adaptimmune's full suite of regulatory documents, keeping pace with ambitious timelines on multiple TCR-based cancer therapy assets simultaneously. Read the case history → Ageing and frailty Medical Communications FRAILomic Niche built and coordinated the full communications strategy for this 20-institution European initiative, turning complex frailty biomarker research into compelling content for academics, policymakers and the public alike. Read the case history → Respiratory Clinical Operations RASP-UK initiative Since 2014, Niche has run the executive function of this £9.6 million MRC-funded consortium, overseeing seven clinical trials across 13 academic centres to personalise severe asthma treatment. Read the case history → Ageing and frailty Clinical Operations MID-Frail Study When the original CRO walked out mid-trial, Niche stepped in to rescue and deliver this EU-funded, 74-site European study on frailty in older adults with type 2 diabetes. Read the case history → Oncology Regulatory Affairs Astex Pharmaceuticals Niche provided Astex with expert regulatory writing across their oncology pipeline, delivering clinical protocols, study reports and safety narratives largely autonomously and to an exceptionally high standard. Read the case history → Medical devices Medical Communications ApaTech Niche crafted a strategic communications plan for ApaTech's synthetic bone graft portfolio, translating preclinical science into compelling manuscripts, regulatory documents and conference publications ahead of its $330 million acquisition. Read the case history → Multiple areas Regulatory Affairs Assign DMB For over a decade, Assign DMB relied on Niche as their embedded writing partner, seamlessly converting statistical outputs into polished clinical study reports across oncology, asthma and gastroenterology. Read the case history →

Your programme could be the next one.

Tell us where your programme is. We will tell you, honestly, how we can help.

© 2025 Niche.org.uk     All rights reserved

HomePrivacy policy Corporate Social Responsibility